chang fve
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research may
estim feb
price data may
rate updat may
currenc amount express
methodolog valu compani
post strong fiscal fourth-quart result
larg met full-year top-lin expect nearli
hit expens project nose expect leav
fair valu unchang roll model make
slight near-term adjust project
revenu growth cardiovascular group fell slightli short
expect off-set stronger-than-
expect growth minim
invas
restor therapi group remain confid
firm wide econom moat support continu
adopt innov product steadi stream new
product pipelin across therapeut area
though spine busi character
slow declin decad weve long
pessimist market gener think
addit mazor robot could chang script spur
sustain growth spine unit similar
stryker strategi mako robot hip knee
replac acquisit mazor provid
market-lead footprint emerg area spine
robot think robot contribut spine product
pull-through afford opportun shift practition
higher-margin consum discuss
past joint replac robot current
difficult assess whether spinal robot lead better
patient outcom take year collect clinic data
nonetheless knee replac sizabl
group patient dissatisfi outcom
think contribut appetit among spine
surgeon tri technolog adopt also
bolster secular shift open surgeri
minim invas spine procedur like
benefit real-tim imag precis
effect one way
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
one largest medic devic compani develop
manufactur therapeut medic devic chronic diseas portfolio
spinal fixat devic neurovascular product surgic tool
compani market product healthcar institut physician
unit state oversea foreign sale account
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
analysi transcathet mitral valv technolog pleas
see matter heart revisit transcathet mitral
found issu quarter intrigu
first favor registri data medtron symplic renal
denerv procedur hypertens share last
month three year procedur decreas
systol blood pressur number top
sustain bode well pivot trial current
underway expect see initi data next spring
remain renal denerv lead
think uncontrol hypertens market could
second continu think risk-bas
contract tyrx antibacteri envelop help
insul firm competit although fiscal
fourth-quart declin cardiac rhythm
manag heart failur disappoint
contrast domest declin abbott
saw busi last quarter point appear
gain share abbott
bear brunt loss less
third track implant first in-human
transsept deliveri end year firm
alreadi well pivot apollo trial transap
deliveri enter rib upward
left ventricl firm ahead competitor
time standpoint consensu among research
thought leader intervent cardiolog
shift toward transsept deliveri base lower
level success outcom weve seen transap
transcathet aortic valv replac consid
bulkier stent-in-st design intrepid tmv product
weve temper expect well
product re-engin transsept deliveri
requir number tight turn navig left
atrium reach mitral valv detail
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end april
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end april
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
